Literature DB >> 22106694

HLA-DQ A1, -DQB1 and -DRB1 gene polymorphism--in Malay type 1 diabetes mellitus patients and their use for risk prediction.

A G Rohana1, K C Loh, S K Tin, C H Soh, W M Wan Nazaimoon, K Y Fong, K Nor Azmi, B A K Khalid.   

Abstract

HLA-DQA1, -DQB1, and -DRB1 gene polymorphism were analyzed to study type 1 DM susceptibility in Malay patients from Southeast Asia (Malaysia and Singapore). Patients showed significant increases in the occurrence of DQA1*0501 (50.7% vs. 20.4%; RR = 3.97; Pc < 0.01), DQB1*0201 (48% vs. 19.1%; RR = 3.86; Pc < 0.05), and DRB1*0301 (38.7 vs. 6.8%; RR = 8.36; 95% Pc < 0.05). Conversely, significant decreases were noted in the occurrence of DQA1*0601 (14.7% vs. 35.2%; RR = 0.33; Pc = 0.008) and DQB1*0601 (4% vs. 23.5%; RR = 0.16; Pc < 0.05) in type 1 DM patients. Using a logistic regression model, we derived a risk prediction model for type 1 DM in our indigenous Malay population based on the identified HLA genotypes. The RR for type 1 DM increases by a factor of 5.68 for every unit increase in the number of DRB1*0301 allele (P < 0.001), and decreases by a factor of 0.18 per unit increase in the number of DQB1*0601 allele (P < 0.001). After adjusting for these two HLA genotypes, DQA1*0501, DQB1*0201 and DQA1*0601 were not statistically significant as risk predictors. The lower incidence of type 1 DM in the Malay population may be contributed by the genotypic combinations of DR and DQ genes as well as the linkage disequilibria between susceptible and protective alleles.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22106694

Source DB:  PubMed          Journal:  Med J Malaysia        ISSN: 0300-5283


  2 in total

1.  Improving power of genome-wide association studies with weighted false discovery rate control and prioritized subset analysis.

Authors:  Wan-Yu Lin; Wen-Chung Lee
Journal:  PLoS One       Date:  2012-04-09       Impact factor: 3.240

2.  HLA-DQA1 and HLA-DQB1 Gene Polymorphism in Indonesian Children with Type I Diabetes Mellitus.

Authors:  Nur Rochmah; Muhammad Faizi; Yuni Hisbiyah; Anang Endaryanto
Journal:  Appl Clin Genet       Date:  2022-01-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.